GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inoviq Ltd (ASX:IIQ) » Definitions » Price-to-Free-Cash-Flow

Inoviq (ASX:IIQ) Price-to-Free-Cash-Flow : N/A (As of Jun. 04, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Inoviq Price-to-Free-Cash-Flow?

As of today (2024-06-04), Inoviq's share price is A$0.58. Inoviq's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.06. Hence, Inoviq's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Inoviq's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:IIQ's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 25.44
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Inoviq's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-0.06.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -12.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -6.40% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 9.30% per year.

During the past 13 years, Inoviq's highest 3-Year average Free Cash Flow per Share Growth Rate was 57.50% per year. The lowest was -206.50% per year. And the median was 11.50% per year.


Inoviq Price-to-Free-Cash-Flow Historical Data

The historical data trend for Inoviq's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inoviq Price-to-Free-Cash-Flow Chart

Inoviq Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Inoviq Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Inoviq's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Inoviq's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inoviq's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inoviq's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Inoviq's Price-to-Free-Cash-Flow falls into.



Inoviq Price-to-Free-Cash-Flow Calculation

Inoviq's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.58/-0.061
=N/A

Inoviq's Share Price of today is A$0.58.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Inoviq's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Inoviq  (ASX:IIQ) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Inoviq Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Inoviq's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Inoviq (ASX:IIQ) Business Description

Traded in Other Exchanges
N/A
Address
23 Normanby Road, Notting Hill, Melbourne, VIC, AUS, 3168
Inoviq Ltd is engaged in developing and commercializing a portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The company has commercialized the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Its cancer diagnostic pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.

Inoviq (ASX:IIQ) Headlines

No Headlines